13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001274403
Total reported value
$1.1B
$1.1B
9 檔
22.6%
During the Q3 2024 filing period, ARCH Venture Management, LLC (CIK: 0001274403) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $1.1B across 9 reported positions.
In Q3 2024, ARCH Venture Management, LLC adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 0 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BEAM | Beam Therapeutics Inc | Stock-Other | 45.46% | -1.82% | -11.18% | |
| 2 | RAPP | Rapport Therapeutics Inc | Stock-Other | 29.31% | -3.11% | — | |
| 3 | ERAS | Erasca Inc | Stock-Other | 11.58% | -5.14% | — | |
| 4 | QTTB | Q32 Bio Inc | Stock-Other | 5.49% | -0.30% | EXIT | |
| 5 | ✓ | Verve Therapeutics Inc | Stock-Other | 3.73% | — | — | |
| 6 | GOSS | Gossamer Bio Inc | Stock-Other | 3.05% | -0.27% | — | |
| 7 | ✓ | Stock-Other | 0.76% | — | — | ||
| 8 | UNBX | Unity Biotechnology Inc | Stock-Other | 0.57% | — | — | |
| 9 | FENG | Phoenix New Media Limited | Stock-Other | 0.05% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | QTTB | Q32 Bio Inc | +3.3% | — | Unchanged |
| 2 | ERAS | Erasca Inc | +1.8% | — | Unchanged |
| 3 | ✓ | +0.4% | — | Unchanged | |
| 4 | GOSS | Gossamer Bio Inc | +0.3% | — | Unchanged |
| 5 | UNBX | Unity Biotechnology Inc | +0.1% | — | Unchanged |
| 6 | ✓ | Verve Therapeutics Inc | +0.1% | — | Unchanged |
| 7 | FENG | Phoenix New Media Limited | -0.1% | — | Unchanged |
| 8 | BEAM | Beam Therapeutics Inc | -2.5% | -11.18% | Trim |
| 9 | RAPP | Rapport Therapeutics Inc | -3.3% | — | Unchanged |
According to official SEC Form 13F filings, ARCH Venture Management, LLC reported a total U.S. public equity portfolio value of $1.1B across 9 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BEAM, RAPP, ERAS) accounted for 22.6% of total reported equity market value during Q3 2024.
Top Position Liquidated / Trimmed
BEAM
前期市值: $127.5M
During Q3 2024, ARCH Venture Management, LLC's top holdings by market value included BEAM (45.5%)、RAPP (29.3%)、ERAS (11.6%). The largest single position, BEAM, represented 45.5% of total portfolio value.
In Q3 2024, ARCH Venture Management, LLC made 1 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.